Secor Capital Advisors’s Haemonetics HAE Stock Holding History

Secor Capital Advisors’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-80,437	Closed	-$7.21M	–	484
2018 Q2	$7.21M	Buy	80,437 +26,543	+49%	+$2.24M	0.62%	25
2018 Q1	$3.94M	Buy	+53,894	New	+$3.7M	0.32%	97
2016 Q4	–	Sell	-60,371	Closed	-$2.19M	–	541
2016 Q3	$2.19M	Buy	60,371 +11,892	+25%	+$408K	0.24%	128
2016 Q2	$1.41M	Buy	+48,479	New	+$1.47M	0.18%	190
2016 Q1	–	Sell	-20,958	Closed	-$676K	–	663
2015 Q4	$676K	Buy	+20,958	New	+$680K	0.19%	178
2014 Q4	–	Sell	-10,460	Closed	-$365K	–	410
2014 Q3	$365K	Buy	+10,460	New	+$373K	0.21%	182

Other funds holding HAE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Secor Capital Advisors's HAE Position: Q3 2018 in Review

Secor Capital Advisors sold out of Haemonetics (HAE) in Q3 2018, closing a stake of 80,437 shares — an estimated $7.21M sold.

Secor Capital Advisors first reported a position in HAE in Q3 2014 and held it in 6 quarters. The position peaked at $7.21M in Q2 2018. 292 funds tracked by Wall St. Rank hold HAE as of Q3 2018.

Secor Capital Advisors reported no remaining Haemonetics position as of Q3 2018 after selling out during the quarter.
Secor Capital Advisors sold 80,437 Haemonetics shares in Q3 2018, an estimated $7.21M.
Secor Capital Advisors first reported a position in Haemonetics in Q3 2014 and held it in 6 quarters.
Secor Capital Advisors's Haemonetics position peaked at $7.21M in Q2 2018.
292 funds tracked by Wall St. Rank held Haemonetics as of Q3 2018.

Based on Secor Capital Advisors's 13F filing for Q3 2018, filed 14 Nov 2018.